Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -19.30 | 37.05 |
| PEG Ratio (TTM) | -0.68 | 11.98 |
| P/S Ratio (TTM) | 0.77 | 14.61 |
| P/B Ratio (TTM) | 1.30 | 18.78 |
| P/FCF Ratio (TTM) | 27.66 | 42.97 |
| Price to 5YR AVG Earnings Ratio | -8.96 | 32.96 |
| Price to 5YR AVG FCF Ratio | -13.87 | 63.36 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.07% | 12.20% |
| ROE (TTM) | -6.71% | -7.48% |
| Net Profit Margin (TTM) | -3.04% | 24.97% |
| ROIC 5YR AVG | -8.23% | 4.50% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 6.57% | -15.15% | 4.69% |
| Revenue | 2.42% | -0.45% | 28.54% |
| Net Income | 6.78% | -15.59% | 3.26% |
| Cash Flow | 736.24% | -307.63% | 1,219.98% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.59 | 1.43 |
| Quick Ratio (TTM) | 1.44 | 1.41 |
| D/E Ratio (TTM) | 0.65 | 1.24 |
| Interest Coverage (TTM) | 0.22 | 35.48 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 2.83 | 9.32 |
| LTL to 5YR AVG FCF | -4.61 | 5.27 |
| Shares Outstanding Growth 5YR AVG | 1.85% | 0.66% |